Angiotensin II type 1 receptor gene polymorphism and telomere shortening in essential hypertension

Molecular and Cellular Biochemistry

Volumn 351, Issue 1-2, 2011, Pages 13-18

  Farrag, Wael ^a   Eid, Manal ^a   El Shazly, Sherien ^a,b   Abdallah, Manal ^a  

^a TANTA UNIVERSITY   (Egypt)

^b NONE   (Egypt)

Author keywords

Angiotensin II type 1 receptor; Essential hypertension; Polymorphism; qPCR; RFLP PCR; Telomere length

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CHOLESTEROL; GENOMIC DNA; TRIACYLGLYCEROL;

ALLELE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHROMOSOMES AND CHROMOSOMAL PHENOMENA; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EGYPT; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MALE; POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TELOMERE; TELOMERE SHORTENING;

ADULT; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; GENE FREQUENCY; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTOR, ANGIOTENSIN, TYPE 1; TELOMERE;

EID: 79953709107     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0706-0     Document Type: Article

References (27)

1. Garcia EA, Newhouse S, Caulfield MJ, Munroe PB (2003) Genes and hypertension. Curr Pharm 9:1679-1689 (Pubitemid 36958343)
2. Baudin B (2005) Polymorphism in angiotensin II receptor genes and hypertension. Exp Physiol 90:277-282
3. Weir M (2007) Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Clin Ther 29(9):1803-1824
4. Inagami T, Guo DF, Kitami Y (1994) Molecular biology of angiotensin II receptors: an overview. J Hypertension 12:83-84
5. Takayanagi R, Ohnaka K, Skai Y, Nakao R (1992) Molecular cloning, sequence analysis and expression of a cDNA encoding human type 1 angiotensin II receptor. Biochem Biophys Res Commun 183:910-916
6. Ingelfinger JR (2009) Angiotensin converting enzyme 2 implications for blood pressure and kidney disease. Curr Opin Nephrol Hypertens 18:79-84
7. Wang JL, Xue L, Hao P et al (2010) Angiotensin II type 1 receptor gene A1166C polymorphism and essential hypertension in Chinese: a meta-analysis. J Renin Angiotensin Aldosterone Syst 11:1-9
8. Takami S, Katsuya T, Raguki H (1998) Angiotensin II type 1 receptor gene polymorphism is associated with increased left ventricular mass but not with hypertension. Am J Hypertens 11:316-321 (Pubitemid 28186743)
9. Kainulainen K, Perola M, Terwilliger et al (1999) Evidence for involvement of the type 1 angiotensin II receptor locus in the essential hypertension. Hypertension 33:844-849 (Pubitemid 29140444)
10. Yang Z, Haung X, Jian H et al (2009) Short telomeres and prognosis of hypertension in a Chinese population. Hypertension 53:639-645
11. Blackburn EH (2001) Switching and signaling at the telomere. Cell 106:661-673
12. Epel ES, Blackburn EH, Lin J et al (2004) Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 101:17312-17315 (Pubitemid 39627816)
13. Vasa-Nicotera M, Brouilette S, Mangino M et al (2005) Mapping of a major locus that determines telomere length in humans. Am J Hum Genet 76:147-151 (Pubitemid 40023773)
14. Hunt Sc, Chen W, Gardner JP et al (2008) Leukocyte telomeres are longer in African Americans than in whites: The National Heart, Lung, and Blood Institute Family Heart study and the Bogalusa Heart study. Aging Cell 7:451-458
15. Matsubara Y, Murata M, Watanabe K (2006) Coronary artery disease and a functional polymorphism of hTERT. Biochem Biophys Res Commun 348:669-672 (Pubitemid 44188616)
16. Edo MD, Andres V (2005) Ageing, telomeres, and atherosclerosis. Cardiovasc Res 66:213-221
17. Liu Y, Zhuoma C, Shan G et al (2002) A1166C polymorphism of the angiotensin II type 1 receptor gene and essential hypertension in Han, Tibetan and Yi populations. Hypertens Res 25:515-521
18. Aviva P, Caroline S (2005) Glossary of terms. In: Medical statistics at a glance, 2nd edn. Blackwell, London, pp 144-152
19. Ibrahim MM, Rizk H, Apple LJ et al (1995) Hypertension, prevalence, awareness. Treatment and control in Egypt. Results from the Egyptian national hypertension project. Hypertension 26:886-890
20. Kuriyama S, Tomonari H, Tokudome G et al (2001) Association of angiotensinogen gene polymorphism with erythropoietin-induced hypertension: a preliminary report. Hypertens Res 24:501-505 (Pubitemid 33048915)
21. Castellano M, Muiesan ML, Beschi M et al (1996) Angiotensin II type 1 receptor AC1166 polymorphism. Hypertension 28(6):1076-1080
22. Paillard F, Chansel D, Brand E et al (1999) Genotype phenotype relationships for the renin-angiotensin aldosterone system n a normal population. Hypertension 34:423-429 (Pubitemid 29426758)
23. Moul AK, Shoham DA, Ke North (2008) Angiotensin II type 1 receptor polymorphism and susceptibility to hypertension: a HuGF review. Genet Med 10:560-574
24. Demissie S, Levy D, Benjamin EJ et al (2006) Insulin resistance, oxidative stress, hypertension and leukocyte telomere length in men from the Framingham heart study. Aging Cell 5:325-330 (Pubitemid 44103248)
25. Farzaneh-R LinJ, Epel E et al (2010) Telomere length trajectory and its determinants in persons with coronary artery disease: longitudinal findings from the heart and soul study. Plos One 5(1):8612
26. Minamino T, Miyauchi H, Yoshida T et al (2002) Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 105:1541-1544 (Pubitemid 34297628)
27. Satoh M, Ishikawa Y, Takahashi Y et al (2008) Association between DNA damage and telomere shortening in circulating endothelia progenitor cells obtained from metabolic syndrome patients with chronic artery disease. Atherosclerosis 198:347-353 (Pubitemid 351707385)